KRMD Aug 2024 2.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:39PM EDT. Market open.
Loading interactive chart…
- Business Wire
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
MAHWAH, N.J., May 14, 2024--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, is pleased to announce the signing of a Phase III clinical supply agreement for a novel enzyme replacement therapy to treat a rare endocrinological disease.
- Simply Wall St.
It Looks Like KORU Medical Systems, Inc.'s (NASDAQ:KRMD) CEO May Expect Their Salary To Be Put Under The Microscope
Key Insights KORU Medical Systems to hold its Annual General Meeting on 9th of May Salary of US$563.1k is part of CEO...
- GuruFocus.com
KORU Medical Systems Inc (KRMD) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ...
Discover how KORU Medical Systems achieved its highest quarterly revenue and is strategically positioning for future growth.
© 2024 Yahoo. All rights reserved.